SCYNEXIS Inc.

SCYNEXIS Inc.
Stock Exchange Frankfurt Stock Exchange
EPS
-
Market Cap
-
Shares Outstanding
47.01 M
Public Float
34.43 M
SCYNEXIS Inc.
Stock Exchange NASDAQ Stock Market
EPS
$0.65
Market Cap
$69.21 M
Shares Outstanding
53.65 M
Public Float
46.83 M

Profile

Address
1 Evertrust Plaza
Jersey City New Jersey 07302
United States
Employees -
Website http://www.scynexis.com
Updated 07/08/2019
SCYNEXIS, Inc. engages in the development and commercialization of novel anti-infectives, which addresses the significant unmet therapeutic needs. It develops a novel oral and intravenous drug for several fungal infections, including serious and life-threatening invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.

Financials

View All

Marco Taglietti
President, Chief Executive Officer & Director
Guy MacDonald
Chairman